Home Medizin Das Husker-Forschungsduo wurde als Phase-1-Gewinner der Targeted Genome Editor Delivery Challenge des NIH ausgewählt

Das Husker-Forschungsduo wurde als Phase-1-Gewinner der Targeted Genome Editor Delivery Challenge des NIH ausgewählt

von NFI Redaktion



Two University of Nebraska-Lincoln researchers have been named winners of the first round of a National Institutes of Health competition aimed at developing solutions to deliver genome editing technology to cells of people with rare and common diseases.

Janos Zempleni, Willa Cather Professor of Molecular Nutrition, and Jiantao Guo, Professor of Chemistry, were selected as phase 1 winners of the NIH’s Targeted Genome Editor Delivery Challenge. With a prize of $25,000, Zempleni and Guo will advance the development of universal milk exosomes, natural nanoparticles contained in milk, capable of transporting gene editors to any location in the body.

Zempleni, the project lead and director of the Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules, stated, „With our technology, we could practically treat any disease known to humanity, both rare and common.“

The technology would overcome one of the biggest challenges in using gene editing to treat diseases.

The innovative approach by the Nebraska team is promising and has already shown commercial potential.

Zempleni and Guo are also working towards their Phase 2 application for the TARGETED Challenge in order to further develop and advance their groundbreaking technology.

Source:

University of Nebraska-Lincoln


Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.